Europe Joint Health Technology Assessment Lead

NOTE: The role can be based anywhere in Europe

**OBJECTIVES**:
This role is responsible for overseeing the execution of the European Union Joint Health Technology Assessment (HTA) submissions, leading the Takeda Oncology relationship with the EU HTA agency, the HTA Coordination Group (HTACG) and providing continuous input as an expert on EU Joint HTA guidelines, methods and processes to shape the market access strategy and clinical development plan across Takeda’s oncology portfolio.

**ACCOUNTABILITIES**:

- Co-leads the strategy and development of high quality HTA government submission dossiers for the European Union Join Clinical Assessments (JCA) and Joint Scientific Consultations (JSC) for new oncology medicines with the EUCAN Access Lead
- Lead internal expert on the methodological requirements and specifications for the EU HTA government procedures to complement existing product area expertise
- Shapes relationships with EU government agencies responsible for HTA and is the primary point of contact who represent Takeda in communication and negotiations with EU HTA government authority, HTACG, strategically supporting any necessary adjustments needed to achieve a positive outcome
- Responsible for coordinating the external stakeholder engagement process for JCA submissions in collaboration with EUCAN access lead, EUCAN medical, patient advocacy and country affiliates
- Leads the identification of EU HTACG objections and ensures responses are diligently addressed
- In collaboration with the EUCAN Access Lead:

- Co-leads the EU JCA submission teams, leveraging expertise and collaborating closely with regional, global and LOC members with the
- Co-leads Joint Scientific Consultation to collect feedback on clinical trial considerations to inform clinical development and evidence generation strategies
- Develop and manage strong relationships with EU key opinion leaders, HTA/payers, academic researchers and vendors to ensure excellence in JCA and JSC activities, validation of the market access strategy and dossier assumptions
- As a key member of the Payer Value and Patient Access (PVPA) sub-team, responsible for representing the joint EU HTA archetype in internal regional and global forums including communicating requirements and changes in joint HTA guidelines to inform the global brand, PVPA functional plan and the asset clinical development plans
- Responsible for leading internal communication and educating internal stakeholders on key developments on EU Joint HTA including procedure and method guideline updates
- Responsible for understanding trends, relationships/influence and collaboration of national HTA/payers, regulatory agencies (EMA) with the EU HTA CG and provide these strategic insights to global PVPA. Based on these insights, shape EU joint HTA and reimbursement strategies.

**EDUCATION, BEHAVIOURAL COMPETENCIES AND SKILLS**:
**REQUIRED QUALIFICATIONS**:

- Minimum Bachelor’s degree
- Minimum of 8 years’ experience in healthcare consulting or biopharmaceuticals industry
- Minimum of 5 years’ experience in market access, health economics, pricing, health policy, public health, and/or international affairs showcasing increasing responsibility and experience in the same or similar roles; local affiliate experience is a plus
- Previous direct experience leading a national Health Technology Assessment (HTA) submission including leading the submission team, developing a dossier, setting the submission strategy and stakeholder engagement plan; EUnetHTA experience is a plus
- Strong understanding of the EU payer environment, HTA trends and reimbursement guidance and technical methodologies (NCPE, TLV, G-BA, HAS, etc.) - such as health economics, reimbursement authorities’ decision-making processes, and current issues
- Expertise and hands on experience in health technology assessment tools, value materials, methods, evidence synthesis approaches (indirect treatment comparisons, network meta-analyses) and clinical and HTA/payer insight elicitation (i.e. advisory board)
- Demonstrated strong verbal and written communication skills - previous experience with external stakeholder management, communication with HTA or reimbursement authorities, HCPs and patient organisations
- Well organized with strong project management skills and able to work under pressure.
- Ability to manage complex projects with multiple stakeholders and work well under pressure; previous experience managing complex projects
- Ability to think strategically with strong leadership, collaboration and communication skills

**PREFERRED QUALIFICATIONS**:

- Advanced / graduate degree (MSc, PhD, MPH, MPP, MBA)
- Degree or diploma certificate in health economics or economic evaluations
- Previous experience in Oncology
- Launch experience

**Locations**:
Zurich, Switzerland

**Worker Type**:
Employee

**Worker Sub-Type**:
Regular

**Time Type**:
Full time